Gain Instant Access

Fill out the form to access OSI USA content instantly

What You'll Access by Completing This Form:

Exclusive TIDES USA & TIDES Europe Obesity-Related Recordings Covering the Same Topics as Obesity Science & Innovation USA (OSI USA)

• Andreas Vegge, PhD - Novo Nordisk: Amycretin – A Unimolecular GLP-1 and Amylin Receptor Agonist – From Discovery to Clinical Proof of Concept 
• Claudia Hjørringgaard, PhD - Gubra: Development of Novel Anti-obesity Peptides Using StreaMLine - A Machine Learning-driven Peptide Drug Discovery Platform 
• Michael Byrne, PhD - Wave Life Sciences: INHBE Silencing in Mice Confirms Human Genetic Data and Supports a New Approach for Obesity 
• Leendert van den Bos - EnzyTag BV: Fragment-Based Approaches for the Production of Peptide-based Therapeutics for Diabetes and Obesity 
• Daniel Shanti, MD, PhD - ProLynx LCC: Ultra Long-acting Anti-obesity Peptides

Why Access These Resources
Get a preview of the cutting-edge content that will drive discussions among the 150+ industry leaders gathering in Boston this May to delve deep into cutting-edge obesity research and metabolic health advancements. These exclusive resources cover the same topics and themes that will be explored at OSI USA 2026.

Complete the Form Below to Access Premium Resources Aligned with OSI USA 2026
Don't miss your opportunity to preview the same cutting-edge topics that will be explored at the premier therapeutic development event. Fill out the form now to unlock these premium resources.

Your Dream Home Is a Click Away

Explore our exclusive virtual home tours from the comfort of your couch. See every detail, ask questions, and find the home that’s perfect for you.

Step inside your future home without leaving your current one.